Emerging at the UK, retatrutide, a new compound , is creating considerable buzz within the scientific community regarding its potential for physique management . This dual GIP and GLP-1 receptor agonist seems to provide a substantial advantage over existing therapies, showing promising results in early clinical studies . Researchers believe its par